Analysis of anti-tumor effect and mechanism of GLS1 inhibitor CB-839 in colorectal cancer using a stroma-abundant tumor model.
Miyamoto R, Takigawa H, Yuge R, Shimizu D, Ariyoshi M, Otani R, Tsuboi A, Tanaka H, Yamashita K, Hiyama Y, Urabe Y, Ishikawa A, Sentani K, Oka S.
Miyamoto R, et al. Among authors: tanaka h.
Exp Mol Pathol. 2024 May 2;137:104896. doi: 10.1016/j.yexmp.2024.104896. Online ahead of print.
Exp Mol Pathol. 2024.
PMID: 38703552